Table 4 Relationship between CCT2 and PDIA3 expression and clinicopathological characteristics and average survival of gallbladder SC/ASC patients
Clinicopathological features | Case number | Average survival (months) | χ2 | P |
|---|---|---|---|---|
Gender | ||||
male | 19 | 10.74(6 to 24) | 0.767 | 0.381 |
female | 27 | 9.85(4 to 24) | ||
Age (years) | ||||
≤45 | 3 | 15.67(8 to 24) | 2.023 | 0.155 |
>45 | 43 | 9.84(4 to 24) | ||
Pathological types | ||||
SC | 26 | 10.19(4 to 24) | 0.223 | 0.637 |
ASC | 20 | 10.25(4 to 24) | ||
Degree of differentiationa | ||||
well-differentiated | 16 | 7.04(4 to 11) | ||
moderately-Differentiated | 24 | 8.92(4 to 18) | 19.125 | 0.000 |
poorly-differentiated | 6 | 5.83(4 to 9) | ||
Tumor maximum diameter (cm) | ||||
≤ 3 cm | 20 | 14.35(7 to 24) | 31.337 | 0.620 |
> 3 cm | 26 | 7.04(4 to 11) | ||
Gallbladder stones | ||||
no | 18 | 8.22(4 to 12) | 3.730 | 0.053 |
yes | 28 | 11.50(4 to 24) | ||
TNM stage | ||||
I + II | 12 | 17.00(9 to 24) | ||
III | 20 | 9.20(7 to 15) | 51.139 | 0.000 |
IV | 14 | 5.86(4 to 8) | ||
Lymph node metastasis | ||||
no | 17 | 14.24(4 to 24) | 16.219 | 0.000 |
yes | 29 | 7.86(4 to 15) | ||
Invasion | ||||
no | 16 | 15.75(9 to 24) | 32.271 | 0.000 |
yes | 30 | 7.27(4 to 12) | ||
Surgical | ||||
radical | 16.64(10 to 24) | |||
palliative | 8.50(6 to 12) | 50.165 | 0.000 | |
biopsy | 6.00(4 to 8) | |||
CCT2 | ||||
- | 23 | 12.96(6 to 24) | 14.073 | 0.000 |
+ | 33 | 7.48(4 to 12) | ||
PDIA3 | ||||
- | 20 | 12.75(6 to 24) | 7.011 | 0.008 |
+ | 26 | 8.27(4 to 24) |